8.1 Medication Reconciliation & Identifying Drug-Related Problems

Key Takeaways

  • Systematic home medication reconciliation requires the 'Brown Bag Review' methodology: physical inspection of all prescription containers, OTC drugs, herbal supplements, vitamins, sample packs, topical patches, eye drops, and expired vials across every room of the domicile.
  • Drug-related problems (DRPs) are classified into omission, commission, therapeutic duplication, incorrect dosage/frequency/route, and drug-food or drug-supplement interactions.
  • Transitions of care represent the single highest-risk window for adverse drug events, marked by widespread discordance among hospital discharge summaries, outpatient pharmacy dispensing records, and actual self-administration habits.
  • Inadvertent therapeutic duplication—particularly dual RAAS inhibition (e.g., lisinopril plus losartan) or dual beta-blockade (e.g., carvedilol plus metoprolol)—causes catastrophic clinical events such as severe hyperkalemia, acute kidney injury, profound bradyarrhythmias, and cardiogenic shock.
  • The Community Paramedic closes the communication loop using structured SBAR reporting, collaborating directly with primary care providers, discharging specialists, and dispensing pharmacists to generate a unified, verified personal medication record (PMR).
Last updated: September 2026

8.1 Medication Reconciliation & Identifying Drug-Related Problems

Quick Summary: In Mobile Integrated Healthcare and Community Paramedicine (MIH-CP), medication reconciliation diverges fundamentally from the rapid, complaint-focused medication history gathered during acute 911 EMS transports. Operating within Domain 3 (Patient/Client Centric Care), the Community Paramedic conducts an in-home forensic evaluation of all pharmaceuticals, over-the-counter (OTC) products, and supplements. By resolving discrepancies across hospital discharge orders, pharmacy dispensing records, and actual patient self-administration routines, the clinician prevents life-threatening drug-related problems (DRPs) and reduces avoidable hospital readmissions.

Medication-related adverse events represent one of the leading causes of avoidable hospital readmissions, emergency department recidivism, and premature mortality among individuals with complex chronic diseases. National clinical data consistently demonstrate that over 50% of adult patients experience at least one clinically significant medication discrepancy during transitions of care between acute inpatient hospitalization and community discharge. When patients transition across care settings—from hospital wards or skilled nursing facilities back to independent living—pharmacotherapeutic plans are frequently disrupted by communication breakdowns, redundant prescribing, discontinued medications left in medicine cabinets, and confusion over altered brand versus generic formulations.

While acute care paramedics rapidly identify immediate pharmacologic exposures related to chief complaints (such as acute opioid overdose or anaphylaxis), the Community Paramedic executes a comprehensive, forensic, and longitudinal reconciliation process. The clinician does not simply read a typed medication list; they enter the living space to investigate the physical reality of how medications are procured, organized, understood, and consumed.


The Systematic "Brown Bag Review" Protocol in the Domiciliary Setting

Relying on a patient or family member to recite their current medication regimen is notoriously inaccurate. Patients frequently forget non-oral dosage forms, fail to mention OTC analgesics or herbal remedies, or state they take what is written on an outdated hospital discharge sheet. The gold standard for in-home reconciliation is the comprehensive "Brown Bag Review" methodology.

┌─────────────────────────────────────────────────────────────────────────┐
│               THE DOMICILIARY BROWN BAG REVIEW PROTOCOL                 │
├─────────────────────────────────────────────────────────────────────────┤
│  STEP 1: Active Environmental Retrieval Sweep                           │
│  Search beyond the bedside: nightstands, kitchen cabinets, bathroom     │
│  medicine chests, refrigerator shelves, coat pockets, and purse/bags.   │
├─────────────────────────────────────────────────────────────────────────┤
│  STEP 2: Physical Inspection & Container Forensic Audit                 │
│  Audit imprint codes, fill dates, remaining quantities, multi-pharmacy   │
│  labels, expiration dates, and physical signs of chemical degradation.  │
├─────────────────────────────────────────────────────────────────────────┤
│  STEP 3: Patient & Caregiver Micro-Interview                            │
│  Ask: 'Show me exactly what you take when you wake up.' Reconcile       │
│  label directions with actual self-administration habits and PRN use.   │
├─────────────────────────────────────────────────────────────────────────┤
│  STEP 4: Cross-Referencing Discrepancy Triangulation                    │
│  Triangulate Hospital Discharge Orders vs. Community Pharmacy Dispense  │
│  Logs vs. In-Home Reality. Categorize and document all conflicts.      │
└─────────────────────────────────────────────────────────────────────────┘

Step 1: Active Environmental Retrieval Sweep

With the patient's explicit consent, the Community Paramedic performs a systematic sweep of the residence. Experience demonstrates that high-risk pharmaceuticals are dispersed throughout multiple rooms:

  • Kitchen: Counters, above-sink cupboards, lazy Susans, and the refrigerator door (where insulins, biologics, and reconstituted suspensions are kept).
  • Bathroom Medicine Cabinets: Often laden with high humidity and heat that degrade chemical stability; frequently harbor expired prescriptions from deceased spouses or discontinued regimens.
  • Bedside Tables & Nightstands: The most frequent location for current daily pills, sleep aids, and PRN sedatives.
  • Purses, Pockets, and Travel Bags: Where "emergency" sublingual nitroglycerin, rescue inhalers, and analgesics are stored.
  • Non-Oral Formulations: The paramedic must actively ask for and locate transdermal patches (fentanyl, clonidine, nitroglycerin, lidocaine), ophthalmic drops, nasal sprays, subcutaneous injectables, topical ointments, and rectal suppositories, which patients rarely consider "real medications."

Step 2: Physical Inspection & Container Forensic Audit

Every container retrieved must be examined individually:

  • Vial Label vs. Inner Contents: Open each vial to verify that the physical pills match the label description (color, shape, score marks, imprint codes). Patients frequently consolidate multiple different pills into a single bottle for convenience or pour new refills into old bottles bearing obsolete dosing directions.
  • Dispense Dates and Quantities: Compare the "Date Filled" and "Quantity Dispensed" against the current date. For example, a 30-day supply of an antihypertensive filled 90 days ago that still contains 15 tablets provides undeniable objective evidence of severe medication non-adherence.
  • Multiple Pharmacies & Prescribers: Identify bottles filled at different retail or mail-order pharmacies. Patients using multiple pharmacies bypass centralized automated drug-utilization review (DUR) systems, drastically amplifying the risk of undetected therapeutic duplications.
  • Physical Degradation: Inspect for signs of moisture absorption (crumbling tablets), discoloration, foul odors (e.g., acetic acid/vinegar odor signaling decomposed aspirin), or compromised seals.

Step 3: Patient & Caregiver Micro-Interview

Never ask leading questions such as, "Are you taking your lisinopril 20 mg once a day?" The patient will almost invariably answer "yes." Instead, utilize open-ended, non-judgmental inquiry:

  • "Walk me through your morning. Pick up each bottle you take when you get out of bed and tell me how many you take and what it does for you."
  • "Show me how you measure your liquid heart medication." (Watch for use of uncalibrated household teaspoons, which deliver anywhere from 2.5 mL to 9 mL instead of a true 5 mL metric dose).
  • "What do you take when you have pain, a headache, or trouble sleeping?" (Uncovers hidden OTC NSAIDs, acetaminophen toxicity, or sedating antihistamines).
  • "Do you ever cut your pills in half? How do you do that?" (Identifies crushed or split extended-release capsules/tablets, leading to lethal dose dumping).

Taxonomy of Medication Discrepancies & Drug-Related Problems (DRPs)

To standardize documentation and clinical communication, Community Paramedics categorize identified drug-related problems into five defined taxonomic classes:

Discrepancy CategoryOperational DefinitionHigh-Yield CP Field ExampleAssociated Pathophysiologic HazardImmediate CP Intervention
OmissionA clinically indicated medication prescribed at discharge or pre-admission is unintentionally omitted from the patient's active regimen.Patient discharged on oral anticoagulant (apixaban 5 mg BID) for AFib; neither patient nor outpatient pharmacy filled it due to prior authorization breakdown.High risk of cardioembolic ischemic stroke or systemic arterial embolism within days.Urgent coordination with PCP/care coordinator; obtain immediate bridge supply or prior authorization navigation.
CommissionPatient is ingesting a medication that was never ordered, was explicitly discontinued, or belongs to a household family member.Patient taking discontinued glipizide 10 mg from an old bottle alongside newly initiated basal insulin glargine.Severe, refractory neuroglycopenic hypoglycemia; fall with traumatic brain injury.Physically remove and segregate old bottle; educate patient; verify blood glucose; update reconciled list.
Therapeutic DuplicationConcurrent administration of two or more agents from the identical chemical class or with overlapping pharmacological mechanisms without clinical rationale.Patient taking Lisinopril 20 mg daily from discharge order plus Losartan 50 mg daily from an active pre-admission refill.Profound hyperkalemia ($>6.0\text{ mEq/L}$), acute renal failure, symptomatic orthostatic hypotension.Contact prescriber immediately; discontinue duplicate agent; obtain point-of-care electrolytes and renal panel.
Incorrect Dose, Frequency, or RoutePrescribed agent is taken at a subtherapeutic or supratherapeutic dose, improper interval, or via an erroneous anatomical route.Patient taking Metoprolol Tartrate (short-acting) 50 mg once daily instead of twice daily, or crushing Toprol-XL (extended-release).Loss of rate control / rebound hypertension; or rapid "dose-dumping" profound bradycardia and collapse.Re-educate patient on dosing schedule; instruct pharmacy to dispense uncrushed or immediate-release equivalents.
Drug-Food / Drug-Supplement InteractionPharmacokinetic or pharmacodynamic interference between a pharmaceutical agent and dietary nutrients, herbs, or OTCs.Patient taking Warfarin daily while consuming high-dose OTC St. John's Wort and large volumes of brewed green tea.CYP3A4/P-gp induction or fluctuating Vitamin K intake causing erratic INR, risking either thrombosis or hemorrhage.Order point-of-care INR; educate on dietary consistency; advise immediate cessation of interacting herbal supplements.

Deep Dive: Critical Therapeutic Duplications in Community Practice

Therapeutic duplication represents one of the most hazardous drug therapy problems encountered in mobile integrated healthcare. It frequently arises when hospitalist teams substitute one formulary agent for another without clearly voiding the pre-hospital prescription upon discharge.

1. Dual Renin-Angiotensin-Aldosterone System (RAAS) Blockade

  • Mechanism: Concurrent administration of an Angiotensin-Converting Enzyme (ACE) inhibitor (e.g., Lisinopril, Enalapril, Ramipril) and an Angiotensin Receptor Blocker (ARB) (e.g., Losartan, Valsartan, Candesartan), or the addition of an ARB/Neprilysin inhibitor (Sacubitril/Valsartan).
  • Pathophysiology: Angiotensin II normally constricts the efferent arteriole of the renal glomerulus, maintaining adequate glomerular filtration pressure when renal perfusion plummets. Blocking both ACE and AT1 receptors causes unchecked efferent arteriolar vasodilation, collapsing intraglomerular pressure and causing an acute drop in GFR (acute kidney injury). Simultaneously, the profound suppression of aldosterone secretion in the distal nephron prevents potassium excretion in exchange for sodium, precipitating severe hyperkalemia ($>5.5\text{--}6.5\text{ mEq/L}$) with peaked T waves, broadened QRS complexes, and fatal ventricular arrhythmias.
  • Field Pearl: Dual ACEi + ARB therapy provides no added mortality benefit in heart failure or hypertension and is condemned by international cardiology guidelines.

2. Dual Beta-Adrenergic Blockade

  • Mechanism: Inadvertent overlap of two beta-blockers—most commonly metoprolol (tartrate or succinate) combined with carvedilol, atenolol, or bisoprolol.
  • Pathophysiology: Excessive antagonism of cardiac $\beta_1$-adrenergic receptors profoundly blunts adenylate cyclase activation and intracellular cyclic AMP production. This results in severe negative chronotropy (sinus bradycardia $<45\text{ bpm}$), negative dromotropy (second- or third-degree atrioventricular block), and negative inotropy, crashing cardiac output and plunging the patient into acute decompensated cardiogenic shock.

3. Dual Anticoagulant or Unchecked Antiplatelet Combinations

  • Mechanism: Overlapping full-dose oral anticoagulants (e.g., taking Warfarin alongside newly initiated Apixaban or Rivaroxaban) or "triple therapy" (aspirin + clopidogrel + oral anticoagulant) maintained beyond recommended clinical duration.
  • Pathophysiology: Completely disables both primary platelet aggregation and secondary fibrin mesh formation, resulting in massive gastrointestinal hemorrhage, retroperitoneal bleeding, or spontaneous fatal hemorrhagic stroke.

High-Risk Drug-Food & Drug-Supplement Interactions

Patients rarely report vitamins, minerals, and herbal remedies to healthcare providers, perceiving them as universally "natural and safe." Community Paramedics must vigilantly screen for high-yield interactions:

┌─────────────────────────────────────────────────────────────────────────┐
│            CRITICAL DRUG-FOOD & HERBAL INTERACTIONS TABLE               │
├───────────────────┬─────────────────────────┬───────────────────────────┤
│ Interacting Agent │ Prescribed Pharmaceutical│ Clinical Consequence     │
├───────────────────┼─────────────────────────┼───────────────────────────┤
│ Grapefruit Juice  │ Statins (Simvastatin,   │ Potent CYP3A4 inhibition; │
│ (CYP3A4 inhibitor)│ Atorvastatin), CCBs     │ increases drug levels 3-  │
│                   │ (Amlodipine, Felodipine)│ fold; rhabdomyolysis &    │
│                   │                         │ severe hypotension.       │
├───────────────────┼─────────────────────────┼───────────────────────────┤
│ St. John's Wort   │ Digoxin, DOACs,         │ Potent CYP3A4 & P-gp      │
│ (Enzyme inducer)  │ Cyclosporine, Warfarin  │ inducer; collapses drug   │
│                   │                         │ serum levels; thrombosis, │
│                   │                         │ stroke, graft rejection.  │
├───────────────────┼─────────────────────────┼───────────────────────────┤
│ Leafy Greens      │ Warfarin (Coumadin)     │ Exogenous Vitamin K       │
│ (Spinach, Kale)   │                         │ bypasses VKORC1 block;    │
│                   │                         │ plummets INR (<2.0);      │
│                   │                         │ causes stroke/PE.         │
├───────────────────┼─────────────────────────┼───────────────────────────┤
│ Multivalent Cation│ Fluoroquinolones        │ Chelation in gut lumen;   │
│ Antacids (Ca/Mg/Al│ (Cipro, Levaquin),      │ abolishes drug absorption;│
│ /Iron supplements)│ Levothyroxine (Synthroid│ treatment failure for     │
│                   │                         │ severe infection/hypothy. │
├───────────────────┼─────────────────────────┼───────────────────────────┤
│ 'The 4 Gs'        │ Antiplatelets,          │ Antiplatelet & fibrinolytic│
│ (Ginkgo, Garlic,  │ Anticoagulants, NSAIDs  │ synergy; spontaneous      │
│ Ginger, Ginseng)  │                         │ ecchymosis, GI bleeding.  │
└───────────────────┴─────────────────────────┴───────────────────────────┘

[!WARNING] Chelation Trapping: Multivalent cations ($Ca^{2+}, Mg^{2+}, Al^{3+}, Fe^{2+}$) present in over-the-counter antacids, calcium supplements, and multivitamin preparations bind tightly to oral fluoroquinolones (ciprofloxacin, levofloxacin) and oral thyroid hormone (levothyroxine) within the gastrointestinal tract, forming insoluble chelates that cannot be absorbed. Rule of thumb: Patients must space multivalent cation supplements at least 2 hours before or 4 to 6 hours after taking these medications.


Root Causes of Care Transition Discrepancies

Why do medication lists breakdown so catastrophically between the hospital and the living room? Community Paramedics recognize that discrepancies emerge from three discordant realities:

       [HOSPITAL DISCHARGE SUMMARY]
        Reflects acute inpatient formulary;
        frequently drops home meds or adds short-term
        bridge therapies without clear stopping dates.
                     ▲
                     │ (Discordance & Communication Gaps)
                     ▼
       [OUTPATIENT PHARMACY DISPENSE LOG]
        Reflects what was refilled;
        blind to non-network retail pharmacies,
        mail-order systems, samples, and VA dispensaries.
                     ▲
                     │ (Adherence & Financial Failures)
                     ▼
       [ACTUAL PATIENT IN-HOME HABITS]
        The ground truth: what the patient actually
        swallows every morning based on pill appearance,
        symptoms, fear of side effects, and finances.
  1. Inpatient Formulary Substitution: Hospitals frequently substitute an outpatient drug with an in-house equivalent (e.g., patient takes rosuvastatin 20 mg at home; hospital dispenses atorvastatin 40 mg). Upon discharge, the patient is handed a prescription for atorvastatin while their home medicine cabinet still contains rosuvastatin, leading to duplicate ingestion.
  2. Discharge Instruction Ambiguity: Instructions stating "Resume all home medications as previously directed" without explicitly listing what was stopped, modified, or initiated force patients to guess, often resulting in resuming medications the hospitalist intended to discontinue (such as an nephrotoxic NSAID or a discontinued oral hypoglycemic).
  3. Pharmacy Fragmentation: Older adults frequently use multiple pharmacies—a local independent pharmacy for acute antibiotics, a big-box retail chain for $4 generics, and a national mail-order pharmacy for specialty insulins. No single pharmacy database possesses an all-inclusive record of the patient's active pharmacotherapy.

Step-by-Step Worked Clinical Scenario: In-Home Discrepancy Triangulation

Clinical Presentation

A Community Paramedic performs a post-discharge transition-of-care visit for Mr. Arthur Henderson, a 73-year-old male discharged four days prior following a 5-day hospitalization for Acute Decompensated Heart Failure (HFrEF, EF 30%) and Atrial Fibrillation.

Triangulating the Three Medication Records

┌────────────────────────────────────────────────────────────────────────┐
│                     DATA TRIANGULATION MATRIX                          │
├──────────────────────────┬─────────────────────────┬───────────────────┤
│ Hospital Discharge Sheet │ Outpatient Pharmacy Log │ In-Home Pill Audit│
├──────────────────────────┼─────────────────────────┼───────────────────┤
│ Furosemide 40 mg PO QD   │ Furosemide 20 mg (30 d) │ Found 20 mg vial; │
│                          │ last filled 45 days ago │ taking 1 tab QD   │
│ Carvedilol 12.5 mg BID   │ Metoprolol Tart 50 mg   │ Taking BOTH       │
│                          │ refilled 10 days ago    │ Carvedilol & Metop│
│ Lisinopril 20 mg PO QD   │ Lisinopril 20 mg filled │ Taking Lisinopril │
│                          │ Losartan 50 mg (90 d)   │ PLUS old Losartan │
│ Apixaban 5 mg PO BID     │ NOT ON FILE             │ None in home!     │
│ Spironolactone 25 mg QD  │ Spironolactone filled   │ In cabinet, UNOPEN│
│ (No OTCs approved)       │ OTC Ibuprofen 800 mg    │ Taking Ibuprofen  │
└──────────────────────────┴─────────────────────────┴───────────────────┘

Objective Patient Assessment Findings

  • Vital Signs: Blood Pressure 88/54 mmHg, Heart Rate 44 bpm regular, SpO2 93% on room air, Respiratory Rate 20 breaths/min.
  • Physical Exam: Bilateral 2+ pitting pretibial edema to mid-calf, JVD at 5 cm above sternal angle at 45 degrees, bibasilar fine inspiratory crackles.
  • Point-of-Care Blood Testing: Potassium $5.8\text{ mEq/L}$ (critical hyperkalemia!), BUN $42\text{ mg/dL}$, Creatinine $2.2\text{ mg/dL}$ (baseline $1.2\text{ mg/dL}$).

Paramedic Identification of Drug Therapy Problems

  1. Severe Therapeutic Duplication (Beta-Blockers): Patient is ingesting Carvedilol 12.5 mg BID and Metoprolol Tartrate 50 mg BID simultaneously. This explains his profound sinus bradycardia (HR 44 bpm) and contributes to hypotension (BP 88/54).
  2. Dangerous Therapeutic Duplication (RAAS Inhibitors): Ingesting Lisinopril 20 mg daily plus Losartan 50 mg daily. This dual blockade has triggered an acute renal failure crisis (Cr 2.2) and severe hyperkalemia ($K^+ 5.8\text{ mEq/L}$).
  3. Critical Medication Omission: Apixaban was never filled because of an unresolved insurance prior authorization, leaving this patient with atrial fibrillation and severe HFrEF at extreme risk for an embolic stroke.
  4. Dosage Omission / Underdosing: Taking old 20 mg furosemide tablets instead of the newly prescribed 40 mg dose; spironolactone is untouched because the patient feared "taking too many water pills." This explains persistent fluid overload (edema, JVD, crackles).
  5. Harmful OTC Commission: Taking OTC ibuprofen for osteoarthritis pain, directly causing renal afferent vasoconstriction, blunting loop diuretic efficacy, and exacerbating renal failure.

Paramedic Intervention & Closing the Loop

  1. Acute Stabilization: Paramedic immediately runs a 12-lead ECG (revealing sinus bradycardia without peaked T waves or widened QRS). Consults online medical direction and heart failure cardiologist via telemedicine.
  2. De-escalation: Under medical orders, the paramedic instructs Mr. Henderson to immediately withhold the metoprolol, losartan, and ibuprofen. The old prescription vials are separated, labeled "DO NOT TAKE - DISCONTINUED," and placed in a quarantine bag.
  3. Loop Closure: Paramedic contacts the outpatient pharmacy and the care transition coordinator to execute the urgent prior authorization for apixaban, and delivers verified instructions for taking Furosemide 40 mg and Spironolactone 25 mg.
  4. Documentation: Generates a unified, verified Personal Medication Record (PMR) in large 16-point bold print, posts it on the refrigerator, and securely transmits the reconciled chart to the primary care provider.

Prescriber Clarification Algorithms & Closing the Loop

When a Community Paramedic uncovers a drug-related problem, resolving it requires structured, unambiguous interprofessional communication. The clinician never alters a prescription unilaterally; instead, they utilize the SBAR Communication Model to collaborate with prescribers:

┌────────────────────────────────────────────────────────────────────────┐
│                     SBAR COMMUNICATION TEMPLATE                        │
├──────────────┬─────────────────────────────────────────────────────────┤
│ SITUATION    │ 'Dr. Smith, this is Community Paramedic Miller visiting │
│              │ Arthur Henderson. I am calling regarding dangerous     │
│              │ therapeutic duplication and hyperkalemia.'              │
├──────────────┼─────────────────────────────────────────────────────────┤
│ BACKGROUND   │ 'Mr. Henderson was discharged 4 days ago for HFrEF. His │
│              │ discharge orders initiated Lisinopril and Carvedilol,   │
│              │ but he is also continuing pre-admission Losartan and    │
│              │ Metoprolol from previous bottles.'                     │
├──────────────┼─────────────────────────────────────────────────────────┤
│ ASSESSMENT   │ 'Current BP is 88/54, HR is 44 bpm, and point-of-care   │
│              │ potassium is 5.8 mEq/L with Creatinine up to 2.2 mg/dL. │
│              │ He is symptomatic with lightheadedness and bradycardia.'│
├──────────────┼─────────────────────────────────────────────────────────┤
│ RECOMMEND-   │ 'I recommend we discontinue the Losartan and Metoprolol,│
│ ATION        │ re-check renal panel in 48 hours, and I will remove the │
│              │ discontinued bottles from his living area.'             │
└──────────────┴─────────────────────────────────────────────────────────┘

The Closed-Loop Reconciled Hand-off Checklist

To ensure durable patient safety, the Community Paramedic executes four closing steps:

  1. Quarantine Discontinued Medications: With patient permission, remove discontinued bottles from active sightlines into a sealed, labeled storage bag or neutralizer pouch to prevent accidental re-ingestion.
  2. Generate the Unified Personal Medication Record (PMR): Create an updated, single-source medication chart detailing Drug Name, Strength, Indication (e.g., "Carvedilol - For your heart failure"), Pill Color/Shape, and Exact Time of Day.
  3. Teach-Back Verification: Have the patient physically demonstrate identifying each morning pill from their newly reconciled bottles.
  4. Cross-System EHR Transmission: Securely route the reconciled list to the patient's primary care clinic, outpatient pharmacy, and discharging hospitalist service.

Common Exam Traps & Clinical Pitfalls

  • Trap: Assuming the typed hospital discharge sheet represents what the patient takes. Exam questions frequently describe a patient with a pristine hospital discharge printout who nevertheless decompensates. In MIH-CP, the written list is only an intention; the physical contents of the home represent the clinical reality.
  • Trap: Believing therapeutic duplication only occurs with identical chemical drugs. Therapeutic duplication includes combining two different drugs from the same therapeutic mechanism (e.g., an ACE inhibitor + ARB, or a Dihydropyridine CCB + Non-Dihydropyridine CCB).
  • Trap: Forgetting non-oral routes during medication histories. Topical patches (e.g., transdermal fentanyl or clonidine) are a frequent source of overdose because patients apply new patches without removing the old ones.
  • Trap: Disposing of discontinued medications without patient consent. Community Paramedics must never seize or discard a patient's property without proper legal authorization, patient agreement, and adherence to state controlled-substance regulations.
Loading diagram...
Systematic In-Home Medication Reconciliation & Discrepancy Resolution Protocol
Test Your Knowledge

A Community Paramedic conducts a post-hospital discharge home visit for a 69-year-old male with chronic hypertension and heart failure. During the 'Brown Bag Review,' the clinician identifies active prescription bottles for Lisinopril 20 mg once daily and Losartan 50 mg once daily. The patient states he swallows both tablets every morning with breakfast. What clinical drug-related problem is present, and what severe physiological hazard does it carry?

A
B
C
D
Test Your Knowledge

During an in-home medication reconciliation, a Community Paramedic observes that a patient taking apixaban (Eliquis) 5 mg twice daily for non-valvular atrial fibrillation has also been taking high-dose over-the-counter St. John's Wort for mild depression. What is the primary clinical pharmacokinetic risk of this combination?

A
B
C
D
Test Your Knowledge

A Community Paramedic discovers that an 81-year-old patient discharged from the hospital three days ago has stopped taking their chronic glaucoma eye drops (timolol ophthalmic) because the medication was not listed on the hospital discharge summary sheet. What is the most appropriate next step for the paramedic?

A
B
C
D